Mayo clinic aims to replace biopsies with urine test for kidney cancer
NCT ID NCT07243067
Summary
This study aims to develop a non-invasive test using urine and blood samples to better identify and classify kidney cancer types. Researchers will analyze tiny particles in urine from 300 patients to find protein markers that distinguish between cancer subtypes. They will also check if blood levels of these particles can predict whether cancer might spread after kidney removal surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.